Avidity Biosciences (RNA) Other Gross PP&E Adjustments (2019 - 2025)
Avidity Biosciences (RNA) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$31.8 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments fell 579.85% year-over-year to -$31.8 million, compared with a TTM value of -$31.8 million through Dec 2025, down 579.85%, and an annual FY2025 reading of -$31.8 million, down 579.85% over the prior year.
- Other Gross PP&E Adjustments was -$31.8 million for Q4 2025 at Avidity Biosciences, down from -$20.9 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $25.9 million in Q2 2025 and bottomed at -$31.8 million in Q4 2025.
- Average Other Gross PP&E Adjustments over 5 years is $1.0 million, with a median of $3.7 million recorded in 2021.
- The sharpest move saw Other Gross PP&E Adjustments soared 884.63% in 2023, then crashed 579.85% in 2025.
- Year by year, Other Gross PP&E Adjustments stood at -$7.9 million in 2021, then dropped by 1.02% to -$8.0 million in 2022, then rose by 10.94% to -$7.1 million in 2023, then skyrocketed by 193.12% to $6.6 million in 2024, then plummeted by 579.85% to -$31.8 million in 2025.
- Business Quant data shows Other Gross PP&E Adjustments for RNA at -$31.8 million in Q4 2025, -$20.9 million in Q3 2025, and $25.9 million in Q2 2025.